ClinicalTrials.Veeva

Menu

Matching Glaucoma With Impaired Cognition (MAGIC)

Sun Yat-sen University logo

Sun Yat-sen University

Status

Enrolling

Conditions

Morbidity of Primary Open Angle Glaucoma

Treatments

Diagnostic Test: Topological perception test

Study type

Observational

Funder types

Other

Identifiers

NCT03695224
2018KYPJ126

Details and patient eligibility

About

Glaucoma is the leading cause of irreversible blindness in the world. The current study is designed to find the underlying relationship between impairment of topological perception and incidence of glaucoma.

Full description

Glaucoma is currently the leading cause of irreversible blindness in the world. It has been a difficult task for ophthalmologists and researchers to diagnose glaucoma, especially in early stage. At present, glaucoma diagnosis mainly relies on OCT and visual field test, which have relatively low sensitivity and specificity at the early stage of glaucoma. Previous studies mainly focused on ocular manifestation of glaucoma. However, there was evidence that abnormalities of visual pathway also existed in patients with glaucoma, indicating cerebral cognitive defects may also be involved in glaucoma development. Thus, the current study was designed, in which subjects at high-risk of developing glaucoma are separated into two group based on test results of topological perception. After five years' follow-up, morbidity of primary open-angle glaucoma would be compared between groups to see if there was any relationship between impaired cognitive function and incidence of glaucoma.

Enrollment

3,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Aged between 18-55;
  2. Best corrected visual acuity ≥ 0.6, capable of completing routine glaucoma examinations;
  3. Spherical equivalent < 3D;
  4. No history of other ocular diseases (except mild cataract), including diabetic retinopathy, age-related macular degeneration, optical neuropathy, eye trauma, strabismus, nystagmus, severe dry eye, ptosis of the eyelid, etc.

Exclusion criteria

  1. Unable or unwilling to sign informed consent, or cannot comply with the study protocol
  2. Diagnosed with any kind of glaucoma (based on visual field and OCT, etc) or primary angle-closure diseases(primary angle closure suspect and primary angle closure, based on gonioscopy and UBM examination);
  3. History of ocular surgeries or laser;
  4. Diagnosed with specific neurologic diseases or psychiatric disorders: Parkinson's disease, Alzheimer's disease, anxiety, depression, schizophrenia, etc.(based on scale screening)
  5. With severe systemic diseases: diabetes mellitus, hypertension(systolic pressure≥160mmHg or diastolic pressure≥100mmHg ), heart diseases, kidney diseases, rheumatological disorder, digestive diseases, cancer, etc.
  6. Pregnancy or lactation

Trial design

3,000 participants in 2 patient groups

Group A
Description:
Subjects with normal topological perception
Treatment:
Diagnostic Test: Topological perception test
Group B
Description:
Subjects with abnormal topological perception
Treatment:
Diagnostic Test: Topological perception test

Trial contacts and locations

1

Loading...

Central trial contact

Xiulan Zhang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems